DEVELOPMENT AND IN VITRO EVALUATION OF MUCOADHESIVE BILAYER BUCCAL TABLETS OF CARVEDILOL

  • Ahmed Abd Elbary Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Egypt
  • Amna M. A. Makky Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Egypt, Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Misr University for Science and Technology (MUST), Giza, Egypt.
  • Mina Ibrahim Tadros Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Egypt
  • Ahmed Adel Alaa-eldin Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Misr University for Science and Technology (MUST), Giza, Egypt.

Abstract

Objectives: Carvedilol (CVD) is a nonselective β-adrenergic blocker that suffers from low absolute bioavailability (25-35%) due to first-pass metabolism. CVD-loaded buccal tablets were developed as a promising approach to overcome this limitation.

Methods: The bilayers tablets were prepared by the direct compression technique. CVD-containing layer was based on one of four high molecular weight polymers; hydroxy propyl methylcellulose K15M (HPMC), Polyethylene oxide WSR N-750 (PEO), chitosan (CH) and Eudragit® RS-100 (EUD). An occlusive backing of ethylcellulose 20 (Ethocel®) was adopted as a second layer. The tablets were characterized for weight variation, thickness, friability % and drug content. Further studies were conducted to evaluate their swelling indices, surface pH, in vitro adhesion retention periods and in vitro drug release profiles.

Results: The prepared tablets followed the compendial requirements for thickness, friability %, drug content and weight variation. The surface pH of all tablets ranged from 6.43 to 7.44 while their adhesion retention periods varied from 3.12 to 4.24 h. The best achieved system (PEO-based matrix; F4) displayed a reasonable adhesion retention period and a promising sustained drug release profile, over at least 8 hours, following non-fickian diffusion kinetics. This could indicate the contribution of swelling and erosion mechanisms for drug release.

Conclusions: The current work succeeded in developing and evaluation of promising mucoadhesive CVD matrices suitable for buccal administration. Further pharmacokinetic and clinical studies are suggested to confirm the ability of the best achieved system to avoid the first pass metabolism of CVD and improve patient compliance.

 

Keywords: Carvedilol, Buccal, Bilayer tablets, Polymers

Downloads

Download data is not yet available.

References

1. Harris D, Robinson JR. Drug delivery via the mucous membranes of the oral cavity. J Pharm Sci 1992;81:1–10.
2. Singh B, Chakkal SK, Ahuja N. Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology. AAPS Pharm Sci Tech 2006;7:1–10.
3. Hao J, Heng PWS. Buccal delivery systems. Drug Dev Ind Pharm 2003;29:821–32.
4. Hoogstraate JAH, Wertz PW. Drug delivery via the buccal the buccal mucosa. J Pharm Sci Tech Today 1998;1:309-16.
5. Martindale. The complete drug reference. 33thed. pharmaceutical press London; 2002. p. 931-2.
6. Tripathi KD. Essentials of medical pharmacology. 5thed; 2013. p. 508.
7. Satishbabu BK, Shinivasan BP. Preparation and evaluation of buccoadhesive films of carvedilol. Indian J Pharm Sci 2008;70:175-9.
8. United States Pharmacopeia and National Formulary USP 36–NF 31. The United States Pharmacopeial Convention, Inc.-Rockville MD, Electronic version; 2013.
9. Yamagar M, Kadam V, Hirlekar R. Design and evaluation of buccoadhesive drug delivery system of metoprolol tartrate. Int J Pharm Tech Res 2010;2:453-62.
10. Darwish MK, Elmeshad AN. Buccal mucoadhesive tablets of flurbiprofen: characterization and optimization. Drug Discoveries Ther 2009;3:181–9.
11. Patel VM, Prajapati BG, Patel MM. Formulation, evaluation, and comparison of bilayered and multilayered mucoadhesive buccal devices of propranolol hydrochloride. AAPS Pharm Sci Tech 2007;8:147–54.
12. Tadros MI, Fahmy RH. Controlled-release triple anti-inflammatory therapy based on novel gastroretentive sponges: Characterization and magnetic resonance imaging in healthy volunteers. Int J Pharm 2014;472:27-39.
13. Mohammadi-Samani S, Bahri-Najafi R, Yousefi G. Formulation and in vitro evaluation of prednisolone buccoadhesive tablets. Farmaco 2005;60:339-44.
14. Korsmeyer RW, Gurny R, Docler E, Buri P, Peppas NA. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm 1983;15:25–35.
15. Abdelbary GA, Tadros MI. Design and in vitro/in vivo evaluation of novel nicorandil extended release matrix tablets based on hydrophilic interpolymer complexes and a hydrophobic waxy polymer. Eur J Pharm Biopharm 2008;69:1019–28.
16. Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropylmethylcellulose (HPMC). Adv Drug Delivery Rev 2001;48:139–57.
17. Abd-Elbary A, Tadros MI, Alaa-Eldin AA. Sucrose stearate-enriched lipid matrix tablets of etodolac: modulation of drug release, diffusional modeling and structure elucidation studies. AAPS Pharm Sci Tech 2013;14:656-68.
18. Chaudhari SR, Harsulkar AA. Design and in-vitro evaluation of mucoadhesive buccal tablets ofcarvedilol. Int J Pharm Tech Res 2012;4:1827-33.
19. Peh KK, Wong CF. Polymeric films as vehicle for buccal delivery: swelling, mechanical, and bioadhesive properties. J Pharm Pharm Sci 1999;2:53-61.
Statistics
407 Views | 483 Downloads
How to Cite
Elbary, A. A., A. M. A. Makky, M. I. Tadros, and A. A. Alaa-eldin. “DEVELOPMENT AND IN VITRO EVALUATION OF MUCOADHESIVE BILAYER BUCCAL TABLETS OF CARVEDILOL”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 7, no. 9, July 2015, pp. 172-6, https://innovareacademics.in/journals/index.php/ijpps/article/view/7328.
Section
Original Article(s)